Search Results - "Oshima, Keiko"
-
1
A novel T cell-redirecting anti-GPRC5D × CD3 bispecific antibody with potent antitumor activity in multiple myeloma preclinical models
Published in Scientific reports (01-03-2024)“…G-protein-coupled receptor class 5 member D (GPRC5D) is detected in malignant plasma cells in approximately 90% of patients diagnosed with multiple myeloma…”
Get full text
Journal Article -
2
Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist
Published in Bioorganic & medicinal chemistry letters (15-02-2012)“…A description of the discovery process of CS-2100, a potent, orally active, S1P3-sparing S1P1 agonist has been provided. Its 4-ethyl thiophene structure…”
Get full text
Journal Article -
3
Discovery of CS-0777: A Potent, Selective, and Orally Active S1P1 Agonist
Published in ACS medicinal chemistry letters (12-05-2011)“…CS-0777 (3) is phosphorylated in vivo, and the phosphate of CS-0777 (CS-0777-P) (4) acts as a selective S1P receptor-1 (S1P1) modulator. We report herein the…”
Get full text
Journal Article -
4
Synthesis and SAR of 1,3-thiazolyl thiophene and pyridine derivatives as potent, orally active and S1P3-sparing S1P1 agonists
Published in Bioorganic & medicinal chemistry letters (01-05-2012)“…A series of 1,3-thiazole derivatives were synthesized as potent, orally bioavailable S1P3-sparing S1P1 agonists. One of them, 24c, exhibited favorable efficacy…”
Get full text
Journal Article -
5
Synthesis and evaluation of CS-2100, a potent, orally active and S1P3- sparing S1P1 agonist
Published in European journal of medicinal chemistry (01-05-2012)“…Modulators of sphingosine phosphate receptor-1 (S1P1) have recently been focused as a suppressant of autoimmunity. We have discovered a 4-ethylthiophene-based…”
Get full text
Journal Article -
6
Discovery of CS-0777: A Potent, Selective, and Orally Active S1P 1 Agonist
Published in ACS medicinal chemistry letters (12-05-2011)Get full text
Journal Article -
7
Evaluation of species difference in peripheral lymphocyte reduction effect of CS-0777, a sphingosine 1-phosphate receptor modulator, based on a pharmacokinetic/pharmacodynamic model analysis
Published in Biopharmaceutics & drug disposition (01-12-2016)“…Pharmacokinetic (PK) and pharmacodynamic (PD) modeling was conducted for the reduction of peripheral lymphocytes after oral administration of CS‐0777 to…”
Get full text
Journal Article -
8
Synthesis and evaluation of CS-2100, a potent, orally active and S1P(3)- sparing S1P(1) agonist
Published in European journal of medicinal chemistry (01-05-2012)“…Modulators of sphingosine phosphate receptor-1 (S1P(1)) have recently been focused as a suppressant of autoimmunity. We have discovered a…”
Get full text
Journal Article